CLINICAL_TRIALS
trial_result
· 2023-04-21
Clinical Trial Update: Study to Assess the Efficacy and Safety of Raxone in LHON Patients [Phase 4]
Summary
Phase 4 trial update for Raxone in Leber's Hereditary Optic Neuropathy (LHON) has completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Santhera Pharmaceuticals | Conditions: Leber's Hereditary Optic Neuropathy (LHON) | Phase 4 | Status: COMPLETED | Results posted: 2023-04-21